JT
CRL icon

Jump Trading’s Charles River Laboratories CRL Stock Holding History

Jump Trading’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$386K Buy
2,212
+601
+37% +$95.9K 0.26% 76
2020
Q1 		$203K Buy
+1,611
New +$242K 0.16% 164
2018
Q4 		– Sell
-1,700
Closed -$229K – 269
2018
Q3 		$229K Buy
+1,700
New +$210K 0.01% 290

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Jump Trading's CRL Position: Q2 2020 in Review

Jump Trading increased its Charles River Laboratories (CRL) stake by 37% in Q2 2020, buying an estimated $95.9K and bringing the position to 2,212 shares worth $386K. The position accounts for 0.26% of the portfolio, ranked #76.

Jump Trading first reported a position in CRL in Q3 2018 and has held it in 3 quarters since. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

  • Jump Trading held 2,212 shares of Charles River Laboratories worth $386K as of Q2 2020.
  • Jump Trading bought 601 Charles River Laboratories shares in Q2 2020, an estimated $95.9K.
  • Charles River Laboratories made up 0.26% of Jump Trading's portfolio in Q2 2020, its #76 holding.
  • Jump Trading first reported a position in Charles River Laboratories in Q3 2018 and has held it in 3 quarters since.
  • 466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.